From a fundamental viewpoint, CVS Health seems undervalued in terms of enterprise value. Based on the current price, its market capitalization, plus its net debt, represents 0.82 times its revenues.

Currently the stock is oversold and, in the mid-term, is trading in a bearish trend. In the short term, this trend is reversed upon contact with the USD 90.2 area. CVS Health should be able to confirm its increase in the next trading sessions. This support is a trading opportunity in order to anticipate a technical rebound towards USD 98.8.

Therefore, the proximity of the USD 90.2 support is an opportunity to go long on CVS Health. The first goal is a return in the USD 98.8 resistance area, that is a potential of 6.5%. In fact, the security has to cross this area in order to re-establish a bullish trend in the mid term. A stop loss order can be placed under the support currently tested.